Sort   by:  
 Page size 
UnknownSafety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years.
Not available
S-EPMC9706403 | biostudies-literature
UnknownOutcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.
Not available
S-EPMC9555956 | biostudies-literature
UnknownComparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Not available
S-EPMC3991697 | biostudies-literature
UnknownStandard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
Not available
S-EPMC4059359 | biostudies-literature
UnknownGenetic modifiers of liver disease in cystic fibrosis.
Not available
S-EPMC3711243 | biostudies-literature
Sort   by:  
 Page size